Medline Inc. (MDLN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

2Y 5Y 10Y All
Quarterly Annual TTM

Revenue Quarterly

0 3B 6B 9B Q1 '25: 6.6B Q2 '25: 6.9B Q1 '26: 7.4B Q2 '26: 7.7B Q1 '25 Q2 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

0 800M 1.6B 2.4B Q1 '25: 1.8B Q2 '25: 1.9B Q1 '26: 1.8B Q2 '26: 2.2B Q1 '25 Q2 '25 Q1 '26 Q2 '26

Operating Income Quarterly

0 250M 500M 750M Q1 '25: 571M Q2 '25: 642M Q1 '26: 422M Q2 '26: 395M Q1 '25 Q2 '25 Q1 '26 Q2 '26

Net Income Quarterly

0 150M 300M 450M Q1 '25: 319M Q2 '25: 329M Q1 '26: 239M Q2 '26: 139M Q1 '25 Q2 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 2B 4B 6B Q1 '25: 4.8B Q2 '25: 5B Q1 '26: 5.5B Q2 '26: 5.5B Q1 '25 Q2 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

0 250M 500M 750M Q1 '25: 682M Q2 '25: 197M Q1 '26: 412M Q2 '26: 715M Q1 '25 Q2 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

0 250M 500M 750M Q1 '25: 584M Q2 '25: 87M Q1 '26: 316M Q2 '26: 604M Q1 '25 Q2 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 300M 600M 900M Q1 '26: 824.8M Q2 '26: 860.9M Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.